Article Summary:
Sin Chew Daily – 14th January 2022
Throughout history, men’s lifestyles have generally led to a slightly higher risk than women. A World Health Organization (WHO) survey also pointed out that compared to women, men of different socioeconomic statuses have unhealthier lifestyles in their smoking and eating habits, and a higher rate of alcoholism.
In addition to their riskier lifestyle patterns, men are also at higher risk in terms of health. Most men don’t get regular health checkups and often only consult their doctor when there is a health problem, so this increases their individual risk even more.
Dr Tan Hui Meng, Consultant Urologist at Beacon Hospital, said that while health sciences are changing with each passing day, it is a pity that men are still not as good as women in terms of self-care. Tens of thousands of men ignore their own health, which put themselves at even more risk.
Early Detection and Treatment
Prostate cancer grows at a slower rate. If there are no obvious symptoms, men also need to pay more attention, including regular screening, to detect any signs of tumour growth early, and to start treatment as soon as possible.
The most common prostate cancer surgery is called Radical Prostatectomy, which involves removing the entire prostate.
“In rare cases, other post-surgery complications can be life-threatening. There may also be spread of cancer cells during surgical margin retrieval.”
Minimally Invasive Precision Treatment Plan
Radiation oncology is constantly evolving, and Stereotactic Body Radiation Therapy (SBRT) has become one of the treatment options for early-stage prostate cancer, helping to provide patients with improved biochemical quality and less side effects after surgery.
SBRT uses advanced computer technology. Unlike previous treatments for early-stage prostate cancer, SBRT is minimally invasive, meaning patients do not need major surgery. As an outpatient procedure, SBRT allows patients to go back to their daily life the day after surgery without a long postoperative recovery, with fewer side effects.
Dr Mohamed Ibrahim, clinical oncologist and medical director of Beacon Hospital, said that if a patient was recently diagnosed with early-stage prostate cancer, SBRT could be an option, and the cure rate could range from 90 to 95%.
“SBRT is now the new standard of care for early-stage prostate cancer in the U.S. and Europe. You don’t need to lose your prostate because of cancer. At the same time, we hope that more patients will benefit from this treatment option.”
For more information, please scan:
Featured Doctor :
